Welcome to LookChem.com Sign In|Join Free
  • or
C25H17ClN2O2 is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1466565-84-3

Post Buying Request

1466565-84-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1466565-84-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1466565-84-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,4,6,6,5,6 and 5 respectively; the second part has 2 digits, 8 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 1466565-84:
(9*1)+(8*4)+(7*6)+(6*6)+(5*5)+(4*6)+(3*5)+(2*8)+(1*4)=203
203 % 10 = 3
So 1466565-84-3 is a valid CAS Registry Number.

1466565-84-3Relevant academic research and scientific papers

HETEROCYCLIC COMPOUNDS AND USES THEREOF

-

, (2016/04/26)

Compounds of formula I' and formula II' and their pharmaceutical compositions that modulate kinase activity, including PI3 kinase activity for the treatment of diseases and conditions associated with kinase activity, including PI3 kinase activity.

HETEROCYCLIC COMPOUNDS AND USES THEREOF

-

Paragraph 00697, (2015/04/22)

Compounds and pharmaceutical compositions that modulate kinase activity, including PI3 kinase activity, and compounds, pharmaceutical compositions, and methods of treatment of diseases and conditions associated with kinase activity, including PI3 kinase activity, are described herein.

HETEROCYCLIC COMPOUNDS FOR USE IN THE TREATMENT OF PI3K-GAMMA MEDIATED DISORDERS

-

Paragraph 001353, (2015/11/10)

Compounds and pharmaceutical compositions that modulate kinase activity, including PI3 kinase activity, and compounds, pharmaceutical compositions, and methods of treatment of diseases and conditions associated with kinase activity, including PI3 kinase activity, are described herein.

HETEROCYCLIC COMPOUNDS AND USES THEREOF

-

Paragraph 0990, (2013/10/22)

Compounds and pharmaceutical compositions that modulate kinase activity, including PI3 kinase activity, and compounds, pharmaceutical compositions, and methods of treatment of diseases and conditions associated with kinase activity, including PI3 kinase activity, are described herein.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1466565-84-3